Liu develops quantitative susceptibility mapping and other advanced magnetic-field-sensitive MRI acquisition and reconstruction methods to noninvasively map brain iron, myelin, and microstructure with a precision that approaches magnetometric sensing of tissue magnetic properties.
Liu develops ultra-flexible, tissue-scaffold-integrated mesh bioelectronics that become seamlessly incorporated into developing neural tissue, enabling minimally invasive single-cell recording of brain activity with millisecond precision as the brain develops — a bioelectronic sensing platform explicitly aimed at eventual human/clinical translation for understanding neurodevelopmental disease.
Liu's group sits at the junction of DNA nanotechnology and nanophotonics: DNA-origami-templated plasmonic assemblies, reconfigurable artificial nanomachines whose motion is read out optically (chiral plasmonics, FRET), and, increasingly, synthetic-cell systems -- DNA-based pores and a programmable DNA-origami nanosyringe for directed membrane translocation, the latter published jointly with Nussberger's biophysics group at Stuttgart. The through-line is building nanoscale machines that both actuate and report. Relative to the established NV-ensemble quantum-sensing playbook (DEER, nanoscale NMR, T1 relaxometry at pT/sqrt(Hz) ensemble sensitivity), the relevance is on the biosensing axis: this is the group that can put a nanoscale probe exactly where you want it on or through a membrane, which is the delivery problem that in-cell quantum sensing keeps running into. Preferred-attribute note: nanofabrication is heavily used, but the emphasis is on single-molecule optical readout rather than device manufacture per se.
Maharbiz pioneered millimeter- and sub-millimeter-scale 'neural dust' motes that use ultrasonic power and backscatter telemetry for wireless, batteryless neural and physiological sensing, alongside other micro/nanoscale bioelectronic interfaces.
David Maresca's lab pushes the boundaries of biomedical ultrasound imaging. Research: (1) functional ultrasound imaging of the brain at cellular resolution (vascular signal decoding, brain-computer interface applications); (2) engineering gas vesicle and microbubble acoustic contrast agents as genetically-encoded biosensors; (3) ultrafast ultrasound for cardiac imaging. The lab aims to image individual cells deep inside living organs using next-generation ultrasound. NWO Vici Grant (2026); Chan Zuckerberg Initiative Dynamic Imaging grant.
Marko's lab applies statistical mechanics and single-molecule micromanipulation -- principally magnetic tweezers -- to chromosome structure and DNA-protein interactions, studying how condensin, topoisomerases, and other nucleoid-associated proteins organize and mechanically stabilize chromatin and mitotic chromosomes in vivo and in vitro. The group combines force spectroscopy with fluorescence microscopy to resolve single-DNA and single-chromosome mechanics at the piconewton scale.
Marriott engineers reversibly photoswitchable fluorescent and bioluminescent proteins and uses optical lock-in detection to achieve high-contrast, super-resolution imaging of specific proteins deep within scattering tissue.
McGinty develops fluorescence lifetime imaging (FLIM) instrumentation, including endoscopic and widefield FLIM systems, for applications in cancer diagnosis and metabolic/functional imaging.
McKendry co-directs Q-BIOMED, the UK's national quantum-biomedical-sensing research hub (UKRI/NIHR, ~GBP24M), which brings NV-diamond and other quantum sensors into clinical diagnostics. Her own group has developed nitrogen-vacancy nanodiamond-labelled lateral-flow and rapid molecular tests -- including a quantum-enhanced SARS-CoV-2 antigen test and single-molecule HIV RNA detection -- that exploit resonant microwave control of the NV spin state to separate signal from background and push rapid point-of-care diagnostics toward single-molecule sensitivity, a direct human-diagnostics application of quantum sensing.
Meade designs bioinorganic coordination complexes and nanoparticle- and genetically-encoded contrast agents that act as activatable molecular MRI sensors, reporting on enzyme activity, gene expression, and neurochemistry in living tissue, alongside electronic biosensors and transcription-factor inhibitors for molecular imaging and diagnostics.